Notes to the Accounts
for the year ended 31st March, 1988
!
Notes
Amounts in £ thousands
1. Accounting (i) Accounting Convention
Policies
2. Format
Notes
1988
1987
Amounts in £ thousands
1988
1987
The Sections of Biology and Surgery and Human Genetics were disbanded on 1st April, 1987 and 30th September, 1987 respectively. The research teams in these Sections were reallocated to the Sections of Pathology, Medicine and the new Section of Human Cancer Genetics which was created on 1st October, 1987.
The accounts are prepared under the historical cost convention. (ii) Property, Buildings and Fixed Plant
The costs of property, building and fixed plant held for the purposes of research have been fully written off due to their specialised nature. No account is taken of the value of the residential property used to accommodate visiting scientists and students.
(iii) Equipment
The value of equipment donated or purchased during the year is written off in the Income and Expenditure Account.
(iv) Stock
The Institute takes no account of the value of items in stock at the year end.
(v) Investments
Investments are included in the Balance Sheet at cost; or if bequeathed to The Institute, at probate value, or if given to The Institute, at market value at the date of the gift. Investments held overseas have been converted at the rates of exchange at the date of purchase, probate or gift.
Investment income is the amount received in the year.
(vi) Taxation
All recoverable tax is accrued except for that recovered on legacies which is the amount received in the;
(vii)Income from Inventions
year.
Income from Inventions is the amount received in the year and includes recoverable tax.
The accounts disclose all the information required by the Companies Act 1985. In the opinion of the Committee of Management no useful additional information would be disclosed by a Source and Application of Funds Statement and no Statement has been prepared.
Research Section costs include £12,000 for visiting workers expenses funded by external grants (1987: £14.000) and equipment valued at £13,000 and £14,000 that was purchased by, and remains the property of, the Leukaemia Research Fund and the Cancer Research Campaign respectively.
(ii) Scientific Services
Trading Services
These services sell their service or product to research teams. The prices charged are intended to cover only the direct costs of salaries and running expenses; equipment and the related overhead costs are financed either by The Institute solely, or jointly with the Cancer Research Campaign/Medical Research Council.
Non-Trading Services
For these services it is not cost effective to set up and administer such an internal sales mechanism and they are directly financed by The Institute solely, or jointly with the Cancer Research Campaign/Medical Research Council.
Animals
Trading Scientific Services
Expenditure Income
Net (Surplus) Deficit
251
223
28
27
Workshops
167
162
5
(10)
Electron Microscopy
32
16
16
14
Histopathology
25
23
2
14
Media Preparation
41
43
(2)
7
Centralised Glassware
CBL
49
35
14
12
3. Research
Research
3(i)
8597
7803
Sutton
25
11
14
16
Scientific Services
3(ii)
325
424
Hybridoma
32
12
20
19
Academic Services
3(iii)
447
363
Oligonucleotide Synthesis
38
27
11
4
Laboratory building and
renovations
3(iv)
952
434
660
552
108
103
Safety and Welfare Services
3(v)
244
298
Equipment
63
6
143
10565
9322
Furniture
3
669
552
117
246
(i) Research
The Institute is divided into Research Sections according to general objectives but this does not militate against inter- disciplinary work. Sections consist of a number of teams each comprising a group of staff working together on one or more research projects.
The principal research activities are reviewed quinquennially by the Cancer Research Campaign/Institute of Cancer Research Joint Scientific Committee. The cost of approved research is aggregated and an annual award is made to The Institute. These arrangements take into account the need for an expansion or orderly reduction of activities and the reallocation of resources.
Research Sections are as follows:
Non-Trading Scientific Services
Site Laboratory Management 74 Stores Computing
74
77
77
57
57
208
208
159
2349
52
64
Equipment Furniture
15
4
208
208
178
Total Scientific Services
877
552
325
424
Medicine
1135
848
Radiotherapy
660
623
Pathology
864
400
Physics
750
730
Drug Development
1159
1021
Molecular Structure (The CRC
Biomolecular Structure Unit at The
Institute of Cancer Research)
195
138
Cell and Molecular Biology
1101
808
Human Leukaemia (The Leukaemia
Research Fund Centre at The Institute of
Cancer Research)
419
428
Biology & Surgery
606
Human Genetics
108
214
Chemical Carcinogenesis
588
629
Epidemiology
631
582
Human Cancer Genetics
205
7815
7027
Research Equipment
740
763
Furniture
15
9
Commercial Liaison Development Costs
27
4
8597
7803
The production of Hybridomas and Oligonucleotides commenced in October 1986 and February 1987 respectively. In accordance with normal Institute practice the services will have a subsidised trial period of two years. It is the intention that these services should be self financing by 31st March, 1990.
No comments yet.
Private notes are available after approval.